INTERSTELLAR - International Study Evaluating Lupus Outcomes after Anifrolumab Real World Use

Trial Identifier: D3461R00072
Sponsor: AstraZeneca
Start Date: October 2024
Primary Completion Date: November 2026
Study Completion Date: November 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Argentina Buenos Aires, Argentina
Argentina Cordoba, Argentina
China Guangzhou, China
China Shenzhen, China
China Zhongshan, China
Oman Muscat, Oman
Qatar Doha, Qatar
Saudi Arabia Abha, Saudi Arabia
Saudi Arabia Jeddah, Saudi Arabia
Saudi Arabia Riyadh, Saudi Arabia
Taiwan Kaosiung, Taiwan
Taiwan New Taipei City, Taiwan
Taiwan Taichung, Taiwan
Taiwan Taipei, Taiwan